STENO Stock Overview
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Stenocare A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 2.24 |
| 52 Week High | DKK 8.32 |
| 52 Week Low | DKK 1.09 |
| Beta | 0.31 |
| 11 Month Change | 40.00% |
| 3 Month Change | -19.42% |
| 1 Year Change | -32.93% |
| 33 Year Change | -78.67% |
| 5 Year Change | n/a |
| Change since IPO | -94.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| STENO | DK Pharmaceuticals | DK Market | |
|---|---|---|---|
| 7D | 61.2% | 3.0% | 3.4% |
| 1Y | -32.9% | 5.7% | 7.5% |
Return vs Industry: STENO underperformed the Danish Pharmaceuticals industry which returned 5.7% over the past year.
Return vs Market: STENO underperformed the Danish Market which returned 7.5% over the past year.
Price Volatility
| STENO volatility | |
|---|---|
| STENO Average Weekly Movement | 19.7% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in DK Market | 10.5% |
| 10% least volatile stocks in DK Market | 2.5% |
Stable Share Price: STENO's share price has been volatile over the past 3 months compared to the Danish market.
Volatility Over Time: STENO's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Thomas Schnegelsberg | www.stenocare.dk |
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products to patients in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Stenocare A/S Fundamentals Summary
| STENO fundamental statistics | |
|---|---|
| Market cap | DKK 44.76m |
| Earnings (TTM) | -DKK 16.40m |
| Revenue (TTM) | DKK 2.23m |
20.0x
P/S Ratio-2.7x
P/E RatioIs STENO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STENO income statement (TTM) | |
|---|---|
| Revenue | DKK 2.23m |
| Cost of Revenue | DKK 7.85m |
| Gross Profit | -DKK 5.62m |
| Other Expenses | DKK 10.79m |
| Earnings | -DKK 16.40m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | -0.82 |
| Gross Margin | -251.53% |
| Net Profit Margin | -734.67% |
| Debt/Equity Ratio | 14.9% |
How did STENO perform over the long term?
See historical performance and comparison